Home » Newsletters » BioWorld Science

BioWorld Science

June 7, 2005

View Archived Issues

New vitamin D analogue ZK-156979 possesses strong immunosuppressive activity

BAY-58-2667: a promising therapy for severe pulmonary hypertension

Dynavax presents results of a clinical trial with 1018-ISS in allergic asthma

Ramelteon does not impair respiration in patients with COPD or sleep apnea

Clinical evidence supports the use of ciclesonide in asthma

Update on the effects of roflumilast in asthma, COPD and emphysema

Herstatin: a new endogenous insulin sensitizer

First synthetic CRTH2 agonist identified and tested

CP-2117: Novel 2-methoxyestradiol analogue for asthma therapy

Effects of TZP-101 at gastrointestinal and pituitary/hypothalamic level in rats

TH-9507 reported to improve serum lipid parameters

A new study to assess the neuroprotective effects of piclozotan in acute ischemic stroke

U.S. approval for Glumetza

Not approvable letter for Zimycan

Revatio approved for PAH

Celgene studying lenalidomide for complex regional pain syndrome type 1

Somatropin studied in phase II trial for pediatric Crohn's disease

Preclinical studies suggest use for Cardio Vascu-Grow in stroke patients

New phase IIb dose-finding study for obesity drug AOD-9604

Exelixis and Genentech establish new collaboration

Intra-Cellular Therapies licenses preclinical CNS compounds from BMS

Codexis receives milestone payment from Pfizer collaboration

Neurion receives SBIR grant to support antianxiety drug development

HuMax-CD20 effective in killing tumor cells with low levels of CD20

Allon's AL-108 and AL-208 cross blood-brain barrier in preclinical studies

DiaKine acquires IND application for lisofylline

New River reviews pipeline

Taxol approved for endometrial cancer in Japan

Eculizumab, an anti-C5 antibody, has therapeutic potential in severe asthma

New treatments for cancer covered in recent patents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...